3543 results for «2087»
3543 results
PCI after TAVI
17 Feb 2024 – From PCR Tokyo Valves 2024
Through these slides, examine selected cases of percutaneous coronary intervention after TAVI. Explore the case of a successful bailout PCI with en-face view for sinus sequestration after self-expandable TAVI, learn about best management of previous implanted chimney stent during TAVI, and more.
Rapid-fire - LAA closure and plugging
17 Feb 2024 – From PCR Tokyo Valves 2024
In this series of rapid-fire case submissions, explore cases of left atrium appendage closure and plugging. Discover compelling cases such as the transcatheter closure of a very late atrial septal defect device erosion, learn about the importance of transseptal puncture during left appendage closure, and more....
The role of WATCHMAN therapy in optimising results and future perspectives
17 Feb 2024 – From PCR Tokyo Valves 2024
This special session sponsored by Boston Scientific will help you understand the latest status and the value of WATCHMAN therapy, as well as learning about future perspectives of LAA closure by new WATCHMAN FLX pro.
Mitral and tricuspid intervention
17 Feb 2024 – From PCR Tokyo Valves 2024
Consult this session to discover selected clinical cases regarding complex mitral and tricuspid interventions. Gain insights into phenotypes of secondary tricuspid regurgitation in echocardiography, learn about treatment effectiveness and one-year composite endpoint by clip size of TEER for AFMR, and more!
Rapid-fire - TAVI concomitant with CAD
17 Feb 2024 – From PCR Tokyo Valves 2024
In this series of rapid-fire case submissions, explore cases of TAVI concomitant with coronary artery disease. Learn about innovative procedures such as valve-in-valve chimney stenting, intermediate size THV implantation with coronary protection by chimney stenting, and more!
Learn the procedure strategy - Lifetime management of aortic stenosis therapy with self-expandable valve
17 Feb 2024 – From PCR Tokyo Valves 2024
This special session sponsored by Medtronic focuses on learning what characteristic valves should be used to treat aortic stenosis patients with low calcification or with extremely small native aortic annuluses, and what to pay attention to during the procedure.
Selection of the 2024 best clinical cases
17 Feb 2024 – From PCR Tokyo Valves 2024
Explore the most outstanding clinical cases from PCR Tokyo Valves 2024, including a nightmare case with bicuspid aortic valve, pharmaco-invasive management of mechanical valve thrombus with cardiogenic shock, and a TAVR-in-TAVR challenge.
Rapid-fire - Tricuspid valve interventions in various situations
17 Feb 2024 – From PCR Tokyo Valves 2024
Explore a diverse range of tricuspid valve interventions through various rapid-fire case studies. Learn about a successful TEER of torrential pentacuspid tricuspid regurgitation, gain insight into a percutaneous transcatheter balloon valvuloplasty as a bridge therapy for bioprosthetic tricuspid stenosis, and more!
Selection of the 2024 best abstracts
17 Feb 2024 – From PCR Tokyo Valves 2024
Explore the most outstanding abstracts from PCR Tokyo Valves 2024, such as a study on the disparity in impact of bleeding after TAVI on long-term mortality between Asian and Nordic population, learning about two-year clinical outcomes of staged transcatheter mitral edge-to-edge repair after TAVR, and a...
Rapid-fire - Valve-in-Valve TAVI
17 Feb 2024 – From PCR Tokyo Valves 2024
Through these slides, gain valuable insights into valve-in-valve TAVI from a rapid-fire series of scenarios that cover structural valve deterioration after SAPIEN 3 implantation, a successful aortic valve-in-valve with balloon valve fracture and coronary protection, and TAV-in-SAV for an extremely small failed surgical valve.
Nightmare in mitral valve interventions: sharing solutions together
18 Feb 2024 – From PCR Tokyo Valves 2024
This selection of cases showcase nightmare scenarios during mitral valve interventions. Find out what difficulties might arise during MitraClip procedure, and learn how to prevent complications through optimal treatments and bailouts.
New devices for aortic intervention
18 Feb 2024 – From PCR Tokyo Valves 2024
In this session, discover a variety of abstract submissions concerning new devices for aortic intervention. Compare the clinical outcomes of the latest intra-annular devices, examine the differences in debris between SEV and PEV, and learn about PVL improvement after TAVI with a self-expanding valve.
Rapid-fire - Other SHD interventions
18 Feb 2024 – From PCR Tokyo Valves 2024
Structural heart disease might present unusual complications during intervention. In this series of rapid-fire case submissions, learn about intervention on a pregnant patient, complete heart block post TAVR, and TAVR on a nonagerian female.
CAD and TAVI
18 Feb 2024 – From PCR Tokyo Valves 2024
What is the clinical impact of CAD in TAVR recipients and how best to treat it? Through this session, gain insight on how to determine optimal CAD assessment in TAVR recipients, learn the timing of coronary revascularisation pre-TAVR, and understand the exact assessment and treatment of...
TEER for primary mitral regurgitation
18 Feb 2024 – From PCR Tokyo Valves 2024
What are the current indications and future perspectives of using TEER for primary mitral regurgitation? Join this session if you want to gain insight into anatomical evaluation before TEER, learn the procedural strategy for complex primary mitral regurgitation, and explore the specific features of both MitraClip...
TAVI optimisation
18 Feb 2024 – From PCR Tokyo Valves 2024
Consult this series of slides to enhance your understanding of TAVI optimisation through selected studies for PCR Tokyo Valves 2024. Learn about the prognostic value of right ventricle dysfunction after TAVR, explore a risk model in dialysis patients following TAVR, and explore the impact of age...
Tricuspid valve interventions
18 Feb 2024 – From PCR Tokyo Valves 2024
Consult this session if you want to understand T-TEER/TTVR procedure, learn about clinical indication and appropriate patient selection for TEER/TTVR based on TRILUMINATE trial/TRISCEND study, and update your knowledge of current transcatheter technologies for tricuspid regurgitation.
Challenging situations in mitral valve interventions
18 Feb 2024 – From PCR Tokyo Valves 2024
This selection of cases showcases a number of challenging situations in mitral valve interventions and how best to resolve them. Among such complications are a severe afterload mismatch following M-TEER in functional mitral regurgitation, a detached clip in the left atrium, and more.
Rapid-fire - Outcome studies after valvular intervention
18 Feb 2024 – From PCR Tokyo Valves 2024
This session of rapid-fire submitted cases focuses on outcome studies after valvular intervention. Learn about clinical impacts of cerebral micro-bleeds in patients undergoing TAVI, explore the long-term outcomes of Venus P valve for dysfunctional right ventricular outflow tract, and more!
Learn the procedure technique - Lifetime management of aortic stenosis therapy with self-expandable valve
18 Feb 2024 – From PCR Tokyo Valves 2024
In this session, learn all about the excellent characteristics of the latest self-expandable valve system and its use during the lifetime management of aortic stenosis therapy. Find out more about how we can effectively and safely perform procedures for various cases with the latest self-expandable valve,...